Eli Lilly to make weight-loss pill in new $6.5 billion Texas plant

Core Insights - Eli Lilly is set to produce its next-generation experimental weight-loss pill, orforglipron, at a new multi-billion-dollar manufacturing facility in Texas [1] Company Developments - The new manufacturing plant will be dedicated to the production of orforglipron, indicating a significant investment in expanding the company's capabilities in the weight-loss medication market [1]